Photo from wikipedia
e21239Background: Checkpoint inhibitors, such as the PD-1 antibody nivolumab, have been approved for the treatment of several cancer types, including NSCLC. As only a limited subset of NSCLC patien... Click to show full abstract
e21239Background: Checkpoint inhibitors, such as the PD-1 antibody nivolumab, have been approved for the treatment of several cancer types, including NSCLC. As only a limited subset of NSCLC patien...
Keywords:
nsclc;
identifying cell;
treatment;
profiles associate;
cell profiles;
cell
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!